Related by context. Frequent words. (Click for all words.) 71 dose limiting toxicities 68 dose escalation trial 68 limiting toxicity 67 pharmacokinetic profile 66 tolerability 65 Phase 1b 65 Phase Ib 65 dose escalation 64 dose escalation study 64 HGS ETR1 64 antitumor activity 64 IMGN# 64 safety tolerability 63 pharmacokinetics 63 label dose escalation 63 phase IIb 62 Phase 2a trial 62 Phase 2b study 62 investigational oral 62 mcg kg 61 pharmacodynamic 61 Phase IIa trial 61 azacitidine 61 Phase 1b clinical 61 pharmacodynamics 60 mg/m2 60 Phase 2b trial 60 dosing regimens 60 multiple ascending dose 60 tolerability profile 60 single ascending dose 59 humanized monoclonal antibody 59 Zerenex 59 BAY #-# 59 CoFactor 58 efficacy 58 mg dose 58 FOLOTYN 58 AZD# 58 PF # [001] 58 Azixa 58 composite endpoint 58 Serdaxin 58 Cotara 58 NGX# 58 investigational compound 58 prodrug 58 MGCD# [002] 58 Phase 2a clinical 58 eltrombopag 58 antiviral activity 58 immunogenicity 58 GRN#L 58 Perifosine 57 talactoferrin 57 mg BID 57 Phase IIa clinical 57 plasma concentrations 57 AP# [003] 57 ofatumumab 57 RG# [001] 57 vandetanib 57 pharmacokinetic 57 Phase 2a 57 Phase IIb clinical 57 Welchol 57 MGCD# [001] 57 sapacitabine 57 efficacy endpoints 57 placebo controlled 57 Phase IIa 57 non inferiority 57 pralatrexate 56 JANUVIA 56 CA4P 56 eculizumab 56 Tolerability 56 MDV# 56 confirmatory Phase 3 56 Phase IIb 56 adalimumab 56 ONCONASE 56 administered orally 56 GSK # 56 aliskiren 56 monotherapy 56 dosing schedules 55 primary efficacy endpoint 55 ZYBRESTAT 55 ispinesib 55 T DM1 55 Phase 2b clinical 55 mg m 55 evaluable 55 randomized Phase 55 CYT# 55 RECIST criteria 55 blind randomized placebo 55 bortezomib 55 LEVADEX 55 bavituximab